The Company expects to initiate first-in-human study in early 2026, with initial data anticipated H2 2026 Clinical Trial Application (CTA) submission marks the advancement of Tangram’s GalOmic RNAi platform into…
, /PRNewswire/ — mAIbe und LenioBio freuen sich, eine neue strategische Zusammenarbeit bekannt zu geben, die darauf abzielt, die Entdeckung und experimentelle Validierung von monoklonalen Antikörpern der nächsten Generation zu…
, /PRNewswire/ — mAIbe and LenioBio are pleased to announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies. By combining mAIbe’s AI-driven…
In what Ceribell is hailing as a first of its kind, the company received a 510(k) clearance from the FDA for its Clarity algorithm in detecting electrographic seizures in preterm…
Phase 1 study in aggressive brain cancer (Glioblastoma) is the first clinical trial investigation of uTREAT® Site given green light by European Medicines Agency (EMA) and is now open for…
Phase 1 study in aggressive brain cancer (Glioblastoma) is the first clinical trial investigation of uTREAT® Site given green light by European Medicines Agency (EMA) and is now open for…
Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn’s disease (CD) Findings support the therapeutic…
Mechelen, Belgium; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation1, Galapagos received…
Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster dose No safety concerns observed in any age group by an…
, /PRNewswire/ — Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the…